Rectal Cancer Tumor Board

Monday, May 2, 10:30 - 11:30 am

CME Credit Hours: 1

There are now several viable options in managing most rectal cancers. These include numerous options for resection, neoadjuvant treatment, surveillance, and management of metastatic disease. This symposium will review several “real-world” presentations of rectal cancer and discuss various approaches to treatment.


At the conclusion of this session, participants should be able to:
  1. Recognize treatments for locally advanced rectal cancer
  2. Identify treatments for recurrent rectal cancer
  3. Describe treatments for locally advanced rectal cancer


Jorge Marcet, MD, Tampa, FL

Larissa Temple, MD, Rochester, NY

Social Media
Aaron Dawes, MD, Stanford, CA
10:30 am            
Jorge Marcet, MD, Houston, TX
Larissa Temple, MD, Rochester, NY
10:35 am            
Non-operative Management of Rectal Cancer

Management of Proximal and Distal Rectal Cancers in Young Patients
Management of Advanced Rectal Cancers in the Elderly
Management of Locally Invasive and Perforated Rectal Cancer

Matthew Fink, MD, Tampa, FL
Matthew Mutch, MD, St. Louis, MO
Arun Nagarajan, MD, Weston, FL
Rodrigo Pedraza, MD, Portland, OR
Larissa Temple, MD, Rochester, NY
Kirsten Wilkins, MD, Edison, NJ
Robert Zlotecki, MD, PhD, Gainesville, Fl
11:30 am